Home

Samit Hirawat

CIK 1781290 · EVP,Chief Med.Offr.,Drug Dev. · last filed 2026-06-12

Samit Hirawat is an EVP,Chief Med.Offr.,Drug Dev. who has filed 16 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for PCRX, was dated Jun 12, 2026. Across all open-market trades the lifetime net is +$402.3K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $5.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.57M

Companies

2

Total Filings

16

Lifetime Open-Market Net

$402.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PCRX Director 6,405 $24.43 $156.5K $0 2 2026-06-12
BMY EVP,Chief Med.Offr.,Drug Dev. 83,513 $64.84 $5.42M $402.3K 14 2025-04-29

Recent Filings

16 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 PCRX Grant (A) +6,405 $0 EDGAR
2026-01-29 PCRX Grant (A) — $0 EDGAR
2025-04-29 BMY Buy (P) +4,250 $202.2K EDGAR
2025-03-12 BMY Mixed +15,331 -$1.01M EDGAR
2025-02-19 BMY Buy (P) +1,823 $100.0K EDGAR
2024-11-05 BMY Buy (P) +1,830 $100.1K EDGAR
2024-03-12 BMY Mixed +13,034 -$734.2K EDGAR
2023-07-05 BMY Mixed +4,570 -$306.1K EDGAR
2023-03-14 BMY Mixed +21,383 -$1.47M EDGAR
2022-07-05 BMY Mixed +4,570 -$367.8K EDGAR
Showing 1–10 of 16
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.